Cognitive reserve

Last updated

Cognitive reserve is the mind's and brain's resistance to damage of the brain. The mind's resilience is evaluated behaviorally, whereas the neuropathological damage is evaluated histologically, although damage may be estimated using blood-based markers and imaging methods. There are two models that can be used when exploring the concept of "reserve": brain reserve and cognitive reserve. These terms, albeit often used interchangeably in the literature, provide a useful way of discussing the models. Using a computer analogy, brain reserve can be seen as hardware and cognitive reserve as software. All these factors are currently believed to contribute to global reserve. Cognitive reserve is commonly used to refer to both brain and cognitive reserves in the literature.

Contents

In 1988 a study published in Annals of Neurology reporting findings from post-mortem examinations on 137 elderly persons unexpectedly revealed that there was a discrepancy between the degree of Alzheimer's disease neuropathology and the clinical manifestations of the disease: [1] some participants whose brains had extensive Alzheimer's disease pathology, had no or very few clinical manifestations of the disease. Furthermore, the study showed that these persons had higher brain weights and greater number of neurons as compared to age-matched controls. The investigators speculated with two possible explanations for this phenomenon: these people may have had incipient Alzheimer's disease but somehow avoided the loss of large numbers of neurons, or alternatively, started with larger brains and more neurons and thus might be said to have had a greater "reserve". This is the first time this term has been used in the literature in this context.

The study sparked off interest in this area, and to try to confirm these initial findings further studies were done. Higher reserve was found to provide a greater threshold before clinical deficit appears. [2] [3] [4] Furthermore, those with higher capacity showed more rapid decline once becoming clinically impaired, probably indicating a failure of all compensatory systems and strategies put in place by the individual with greater reserve to cope with the increasing neuropathological damage. [5]

Brain reserve

Brain reserve may be defined as the brain's resilience, its ability to cope with increasing damage while still functioning adequately. This passive, threshold model presumes the existence of a fixed cut-off which, once reached, would inevitably lead to clinical manifestations of dementia.

Brain size

A 1997 study found that Alzheimer's disease pathology in large brains did not necessarily result in clinical dementia. [6] Another study reported head circumference to be independently associated with a reduced risk of clinical Alzheimer's disease. [7]

While some studies, like those mentioned, find an association, others do not. This is thought to be because head circumference and other approximations are indirect measures.

Number of neuronal connections

The amount of synapse loss is greater in early onset dementia than in late onset dementia. [8] This might indicate a vulnerability to the manifestation of clinical cognitive impairment, although there may be other explanations.

Structures like the cerebellum contribute to brain reserve. [9] The cerebellum contains the majority of neurons in the brain and participates in both cognitive and motor operations. [10] Cerebellar circuitry is a site of multiple forms of neuronal plasticity, a factor playing a major role in terms of brain reserve. [11]

Genetic component of cognitive reserve

Evidence from a twin study indicates a genetic contribution to cognitive functions. [12] Heritability estimates have been found to be high for general cognitive functions but low for memory itself. [13] Adjusting for the effects of education 79% of executive function can be explained by genetic contribution. [14] A study combining twin and adoption studies found all cognitive functions to be heritable. Speed of processing had the highest heritability in this particular study. [15]

Cognitive reserve

Cognitive reserve also indicates a resilience to neuropathological damage, but the emphasis here is in the way the brain uses its damaged resources. It could be defined as the ability to optimize or maximize performance through differential recruitment of brain networks and/or alternative cognitive strategies. This is an efficiency model, rather than a threshold model, and it implies that the task is processed using less resources or using neural resources more efficiently, resulting in better cognitive performance. Studies use factors like education, occupation, and lifestyle as proxies for cognitive reserve because they tend to positively correlate with higher cognitive reserve.

Education and occupation

More education and cognitively complex occupation are some of the factors that predict higher cognitive abilities in old age. [16] Therefore, two most commonly used proxies to study cognitive reserve are education and occupation. Education is known to play a role in cognitive decline in normal aging, as well as in degenerative diseases or traumatic brain injuries. [17] A higher prevalence of dementia in individuals with fewer years of education has suggested that education may protect against Alzheimer's disease. [18] Moreover, the level of education has a strong impact on adult's lifestyle. Level of education is measured by the number of years an individual spends in school or alternatively, the degree of literacy. [17] Possibly, the level of education itself provides a set of cognitive tools that allow the individual to compensate for the pathological changes. [18] Cognitive Reserve Index Questionnaire (CRIq), devised to assess the level of cognitive reserve in order to provide better diagnosis and treatment, takes into account years of education and possible training courses lasting at least six months to assess the education load on cognitive reserve. [17] Clinically, education is negatively correlated with dementia severity, [19] but positively correlated with grey matter atrophy, intracranial volume, and overall global cognition. [20] [21] Neurologically, education is correlated to greater functional connectivity between fronto-parietal regions [22] and greater cortical thickness in the left inferior temporal gyrus. [23] In addition to the level of education, it has been shown that bilingualism enhances attention and cognitive control in both children and older adults and delays the onset of dementia. It allows the brain to better tolerate the underlying pathologies and can be considered as a protective factor contributing positively to the cognitive reserve. [24] Another proxy for cognitive reserve is the occupation. Studies suggest that occupation may provide additive and independent source of cognitive reserve throughout person's life. The last or the longest job is usually taken into account. Occupation values may vary in terms of cognitive load involved. Some other common indices, such as prestige or salary can also be considered. Working activity measured by CRIq assesses adulthood professions. There are five different levels of working activities available, differing in the degree of intellectual involvement and personal responsibility. Working activity was recorded as the number of years in each profession over the lifespan. [17] Occupation as a proxy for cognitive reserve is positively correlated with local efficiency and functional connectivity in the right medial temporal lobe. [23] More cognitively stimulating occupations are weakly associated with greater memory, but are more strongly correlated with greater executive functioning. [21] These two proxies are typically measured together and are typically highly correlated with each other. [21] A genetic study using Mendelian randomization analysis demonstrated that high occupation levels were associated with reduced risk for Alzheimer’s disease. In addition, this study confirmed that occupational attainment had an independent effect on the risk for Alzheimer’s disease even after taking educational attainment into account. [25]

Lifestyle

For any given level of clinical impairment, there is a higher degree of neuropathological change in the brains of those Alzheimer's disease sufferers who are involved in greater number of activities. This is true even when education and IQ are controlled for. This suggests that differences in lifestyle may increase cognitive reserve by making the individual more resilient. [26] In other words, everyday experience affecting cognition is analogous to physical exercise influencing musculoskeletal and cardiovascular functions. [27] Using cerebral blood flow as an indirect measure of neuropathological damage, lower CBF indicating more damage, it was found that at a given level of clinical impairment leisure activity score was negatively correlated with CBF. [27] In other words, individuals with greater activity score were able to withstand more brain damage and therefore can be said to have more reserve. Mortimer et al. performed cognitive testing on a population of 678 nuns in 1997, in which they showed that different levels of cognitive activity and performance were possible in patients diagnosed with Alzheimer's. One subject showing reduced neocortical plaques survived with mild deficits, despite (or due to) low brain weight.

Lifestyle factors

More recent studies distinguish four modifiable lifestyle factors which influence cognitive health in later life and offer potential to reduce the risk of cognitive decline and dementia. [28] Between 2011 and 2013 the Cognitive Function and Aging Study Wales (CFAS-Wales) collected data from a cohort of 2,315 cognitively healthy participants aged 65 years and over, not only confirming the theory of impacting lifestyle factors but also detecting a mediating effect of cognitive reserve on the cross-sectional association between lifestyle factors and cognitive function in later life.

Findings

Cognitive and social activity: People with high leisure activity of intellectual (reading magazines or newspapers or books, playing cards, games or bingo, going to classes etc.), social (visiting or being visited by friends or relatives, etc.), engaging (helping others with daily tasks, paid work and volunteer work) nature have a significant smaller risk of developing dementia. [27]

Physical activity: Has a strong impact on developing cognitive decline or dementia. [28]

Healthy diet: Research on healthy diets emphasizes the benefits of adhering to the Mediterranean-style diet as protection of cognitive health. [28]

Alcohol consumption: Studies suggest that light-to-moderate alcohol intake is associated with lower risk (once or twice a week or three or four times a week), as were frequent drinking in earlier life is identified as a risk factor for cognitive decline in later life. [28]

Due to the variety of the four lifestyle factors, a lot of different self-report-scales are used to specify the severity of each proxy.

Parkinson's disease

Parkinson's disease is an example for a condition which is associated with the role of cognitive reserve and cognitive impairment. Previous investigation into Parkinson's disease implicated a possible influence of cognitive reserve in the human brain.

According to some studies [29] the so-called Cognitive Lifestyle is seen as a general protective factor that can be mediated though several different mechanisms.

A study from 2015 [30] included the effects of (cognitive) lifestyle on cross-sectional and longitudinal measures. 525 participants with Parkinson’s disease completed different baseline assessments of cognition and provided clinical, social and demographic data. After 4 years 323 participated in a cognition assessment in the follow-up. The researchers therefore used the measures of global cognition dementia severity. It has been shown, that next to the educational level and the socio-economic status a higher level of recent social engagement was also associated with a decreased risk of dementia.  On the other hand, increasing age and low levels of social engagement may increase the risk of dementia in Parkinson’s disease.

Global reserve

In spite of the differences in approach between the models of brain reserve and cognitive reserve, there is evidence that both might be interdependent and related. This is where the computer analogy ends, as with the brain it seems that hardware can be changed by software.

Neurotrophic effect of knowledge

Exposure to an enriched environment, defined as a combination of more opportunities for physical activity, learning and social interaction, may produce structural and functional changes in the brain and influence the rate of neurogenesis in adult and senescent animal model hippocampi. [31] Many of these changes can be effected merely by introducing a physical exercise regimen rather than requiring cognitive activity per se. [32]

In humans, the posterior hippocampi of licensed London taxi drivers was famously found to be larger than that of matched controls, while the anterior hippocampi were smaller. [33] This study shows that people choosing taxi driving as a career (one which has as a barrier to entry—the ability to memorize London's streets—described as "the world's most demanding test (of street knowledge)") have larger hippocampi, but does not demonstrate change in volume as a result of driving. Similarly, while acquiring a second language requires extensive and sustained cognitive activity, it does not appear to reduce dementia risk compared to those who have not learned another language, [34] although lifelong bilingualism is associated with delayed onset of Alzheimer's disease. [35]

Clinical implications

The clinical diagnosis of dementia is not perfectly linked to levels of underlying neuropathology. The severity of pathologies and the deficit in cognitive performance could not have direct relationship. The theory of cognitive reserve explains this phenomenon. Katzman et al. (1998) conducted a study on the autopsy results of 10 people and found a pathology related to Alzheimer's disease. [1] However, the same patients showed no symptoms of Alzheimer's disease during their life time. So, when pathology emerges in the brain, cognitive reserve helps to cope with cognitive decline. Thus, individuals with high cognitive reserve cope better than those with low cognitive reserve even if they have the same pathology. [36] This causes people with high cognitive reserve to go un-diagnosed until damage becomes severe.

Cognitive reserve, which can be estimated clinically, is affected by many variables. The Cognitive Reserve Index questionnaire (CRIq) measures cognitive reserve under three main sources, namely the education, work activities and leisure time activities throughout the individual's lifespan. [37]

It is important to note that cognitive reserve (and the variables associated with it) do not "protect" from Alzheimer's disease as a disease process—the definition of cognitive reserve is based exactly on the presence of disease pathology. This means that the traditional idea that education protects from Alzheimer's disease is false, albeit that cognitive reserve is protective of the clinical manifestations of disease. [31] As of 2010, there was insufficient evidence to recommend any way to increase cognitive reserve to prevent dementia or Alzheimer's. [32] On the other hand, cognitive reserve has a very important impact on neurodegenerative diseases. Patients with high cognitive reserve showed a delay in cognitive decline when compared to patients with low cognitive reserve. However, when the symptoms of cognitive decline become symptomatic, patients with high cognitive reserve show rapid cognitive decline. [38]

The presence of cognitive reserve implies that people with greater reserve who already are suffering neuropathological changes in the brain will not be picked up by standard clinical cognitive testing. Conversely anyone who has used these instruments clinically knows that they can yield false positives in people with very low reserve. From this point of view the concept of "adequate level of challenge" easily emerges. Conceivably one could measure cognitive reserve and then offer specifically tailored tests that would pose enough level of challenge to accurately detect early cognitive impairment both in individuals with high and low reserve. This has implications for treatment and care.

In people with high reserve, deterioration occurs rapidly once the threshold is reached. [33] In these individuals and their careers early diagnosis might provide an opportunity to plan future care and to adjust to the diagnosis while they are still able to make decisions. A cognitive rehabilitation study, conducted with dementia patients, showed that patients with low cognitive reserve had better outcomes from cognitive training rehabilitation when compared to high cognitive reserve. This is due to the fact that the patients with high cognitive reserve had delayed cognitive symptoms and therefore the disease could no longer resist the pathology. Furthermore, the improvement seen in the patients with low cognitive reserve indicates that these patients can build their cognitive reserve as a life-long process. [39]

Related Research Articles

<span class="mw-page-title-main">Dementia</span> Long-term brain disorders causing impaired memory, thinking and behavior

Dementia is the general name for a decline in cognitive abilities that impacts a person's ability to perform everyday activities. This typically involves problems with memory, thinking, and behavior. Aside from memory impairment and a disruption in thought patterns, the most common symptoms include emotional problems, difficulties with language, and decreased motivation. The symptoms may be described as occurring in a continuum over several stages. Dementia ultimately has a significant effect on the individual, caregivers, and on social relationships in general. A diagnosis of dementia requires the observation of a change from a person's usual mental functioning and a greater cognitive decline than what is caused by normal aging.

<span class="mw-page-title-main">Dementia with Lewy bodies</span> Type of progressive dementia

Dementia with Lewy bodies (DLB) is a type of dementia characterized by changes in sleep, behavior, cognition, movement, and regulation of automatic bodily functions. Memory loss is not always an early symptom. The disease worsens over time and is usually diagnosed when cognitive impairment interferes with normal daily functioning. Together with Parkinson's disease dementia, DLB is one of the two Lewy body dementias. It is a common form of dementia, but the prevalence is not known accurately and many diagnoses are missed. The disease was first described by Kenji Kosaka in 1976.

Vascular dementia (VaD) is dementia caused by problems in the blood supply to the brain, resulting from a cerebrovascular disease. Restricted blood supply (ischemia) leads to cell and tissue death in the affected region, known as an infarct. The three types of vascular dementia are subcortical vascular dementia, multi-infarct dementia, and stroke related dementia. Subcortical vascular dementia is brought about by damage to the small blood vessels in the brain. Multi-infarct dementia is brought about by a series of mini-strokes where many regions have been affected. The third type is stroke related where more serious damage may result. Such damage leads to varying levels of cognitive decline. When caused by mini-strokes, the decline in cognition is gradual. When due to a stroke, the cognitive decline can be traced back to the event.

Cognitive disorders (CDs), also known as neurocognitive disorders (NCDs), are a category of mental health disorders that primarily affect cognitive abilities including learning, memory, perception, and problem-solving. Neurocognitive disorders include delirium, mild neurocognitive disorders, and major neurocognitive disorder. They are defined by deficits in cognitive ability that are acquired, typically represent decline, and may have an underlying brain pathology. The DSM-5 defines six key domains of cognitive function: executive function, learning and memory, perceptual-motor function, language, complex attention, and social cognition.

Semantic dementia (SD), also known as semantic variant primary progressive aphasia (svPPA), is a progressive neurodegenerative disorder characterized by loss of semantic memory in both the verbal and non-verbal domains. However, the most common presenting symptoms are in the verbal domain. Semantic dementia is a disorder of semantic memory that causes patients to lose the ability to match words or images to their meanings. However, it is fairly rare for patients with semantic dementia to develop category specific impairments, though there have been documented cases of it occurring. Typically, a more generalized semantic impairment results from dimmed semantic representations in the brain.

Progressive nonfluent aphasia (PNFA) is one of three clinical syndromes associated with frontotemporal lobar degeneration. PNFA has an insidious onset of language deficits over time as opposed to other stroke-based aphasias, which occur acutely following trauma to the brain. The specific degeneration of the frontal and temporal lobes in PNFA creates hallmark language deficits differentiating this disorder from other Alzheimer-type disorders by the initial absence of other cognitive and memory deficits. This disorder commonly has a primary effect on the left hemisphere, causing the symptomatic display of expressive language deficits and sometimes may disrupt receptive abilities in comprehending grammatically complex language.

<span class="mw-page-title-main">Neurofibrillary tangle</span> Aggregates of tau protein known as a biomarker of Alzheimers disease

Neurofibrillary tangles (NFTs) are aggregates of hyperphosphorylated tau protein that are most commonly known as a primary biomarker of Alzheimer's disease. Their presence is also found in numerous other diseases known as tauopathies. Little is known about their exact relationship to the different pathologies.

<span class="mw-page-title-main">Primary progressive aphasia</span> Medical condition

Primary progressive aphasia (PPA) is a type of neurological syndrome in which language capabilities slowly and progressively become impaired. As with other types of aphasia, the symptoms that accompany PPA depend on what parts of the left hemisphere are significantly damaged. However, unlike most other aphasias, PPA results from continuous deterioration in brain tissue, which leads to early symptoms being far less detrimental than later symptoms.

Cognitive impairment is an inclusive term to describe any characteristic that acts as a barrier to the cognition process or different areas of cognition. Cognition, also known as cognitive function, refers to the mental processes of how a person gains knowledge, uses existing knowledge, and understands things that are happening around them using their thoughts and senses. A cognitive impairment can be in different domains or aspects of a person's cognitive function including memory, attention span, planning, reasoning, decision-making, language, executive functioning, and visuospatial functioning. The term cognitive impairment covers many different diseases and conditions and may also be symptom or manifestation of a different underlying condition. Examples include impairments in overall intelligence ,specific and restricted impairments in cognitive abilities, neuropsychological impairments, or it may describe drug-induced impairment in cognition and memory. Cognitive impairments may be short-term, progressive or permanent.

The Nun Study of Aging and Alzheimer's Disease is a continuing longitudinal study, begun in 1986, to examine the onset of Alzheimer's disease. David Snowdon, an Epidemiologist and the founding Nun Study investigator, started the Nun Study at the University of Minnesota, later transferring the study to the University of Kentucky in 1990. In 2008, with Snowdon's retirement, the study returned to the University of Minnesota. The Nun Study was very briefly moved from the University of Minnesota to Northwestern University in 2021 under the directorship of Dr. Margaret Flanagan. The Nun Study is currently housed at the University of Texas Health San Antonio in the Bigg's Institute for Alzheimer's and Neurodegenerative diseases under the continued directorship of Neuropathologist, Dr. Margaret Flanagan.

Mild cognitive impairment (MCI) is a neurocognitive disorder which involves cognitive impairments beyond those expected based on an individual's age and education but which are not significant enough to interfere with instrumental activities of daily living. MCI may occur as a transitional stage between normal aging and dementia, especially Alzheimer's disease. It includes both memory and non-memory impairments. The cause of the disorder remains unclear, as well as both its prevention and treatment, with some 50 percent of people diagnosed with it going on to develop Alzheimer's disease within five years. The diagnosis can also serve as an early indicator for other types of dementia, although MCI may remain stable or even remit.

The prevention of dementia involves reducing the number of risk factors for the development of dementia, and is a global health priority needing a global response. Initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP) which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory a web-based data knowledge and exchange platform, which will collate and disseminate key dementia data from members states. Although there is no cure for dementia, it is well established that modifiable risk factors influence both the likelihood of developing dementia and the age at which it is developed. Dementia can be prevented by reducing the risk factors for vascular disease such as diabetes, high blood pressure, obesity, smoking, physical inactivity and depression. A study concluded that more than a third of dementia cases are theoretically preventable. Among older adults both an unfavorable lifestyle and high genetic risk are independently associated with higher dementia risk. A favorable lifestyle is associated with a lower dementia risk, regardless of genetic risk. In 2020, a study identified 12 modifiable lifestyle factors, and the early treatment of acquired hearing loss was estimated as the most significant of these factors, potentially preventing up to 9% of dementia cases.

<span class="mw-page-title-main">Alzheimer's disease</span> Progressive neurodegenerative disease

Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens, and is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include problems with language, disorientation, mood swings, loss of motivation, self-neglect, and behavioral issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the typical life expectancy following diagnosis is three to nine years.

Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well as those who may develop AD and controls with no signs of cognitive impairment. Researchers at 63 sites in the US and Canada track the progression of AD in the human brain with neuroimaging, biochemical, and genetic biological markers. This knowledge helps to find better clinical trials for the prevention and treatment of AD. ADNI has made a global impact, firstly by developing a set of standardized protocols to allow the comparison of results from multiple centers, and secondly by its data-sharing policy which makes available all at the data without embargo to qualified researchers worldwide. To date, over 1000 scientific publications have used ADNI data. A number of other initiatives related to AD and other diseases have been designed and implemented using ADNI as a model. ADNI has been running since 2004 and is currently funded until 2021.

Florbetaben, a fluorine-18 (18F)-labeled stilbene derivative, trade name NeuraCeq, is a diagnostic radiotracer developed for routine clinical application to visualize β-amyloid plaques in the brain. It is indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) and other causes of cognitive impairment. β-amyloid is a key neuropathological hallmark of AD, so markers of β-amyloid plaque accumulation in the brain are useful in distinguishing AD from other causes of dementia. The tracer successfully completed a global multicenter phase 0–III development program and obtained approval in Europe, US and South Korea in 2014.

A microinfarct is a microscopic stroke generally ranging between 0.1 millimeter and 1 millimeter in size. Microinfarcts can be found in 25-50% of all elderly deceased persons. Microinfarcts may be the second most important cause of dementia, after Alzheimer's disease.

Yaakov Stern is an American cognitive neuroscientist, professor of neuropsychology at Columbia University.

<span class="mw-page-title-main">Limbic-predominant age-related TDP-43 encephalopathy</span> (LATE) -- a form of dementia

LATE is a term that describes a prevalent condition with impaired memory and thinking in advanced age, often culminating in the dementia clinical syndrome. In other words, the symptoms of LATE are similar to those of Alzheimer's disease. 

Rapid eye movement sleep behaviour disorder and Parkinson's disease is rapid eye movement sleep behavior disorder (RBD) that is associated with Parkinson's disease. RBC is linked genetically and neuropathologically to α- synuclein, a presynaptic neuronal protein that exerts deleterious effects on neighbouring proteins, leading to neuronal death. This pathology is linked to numerous other neurodegenerative disorders, such as Lewy bodies dementia, and collectively these disorders are known as synucleinopathies. Numerous reports over the past few years have stated the frequent association of synucleinopathies with REM sleep behaviour disorder (RBD). In particular, the frequent association of RBD with Parkinson's. In the general population the incidence of RBD is around 0.5%, compared to the prevalence of RBD in PD patients, which has been reported to be between 38% and 60%. The diagnosis and symptom onset of RBD typically precedes the onset of motor or cognitive symptoms of PD by a number of years, typically ranging anywhere from 2 to 15 years prior. Hence, this link could provide an important window of opportunity in the implementation of therapies and treatments, that could prevent or slow the onset of PD.

Alzheimer's disease (AD) in African Americans is becoming a rising topic of interest in AD care, support, and scientific research, as African Americans are disproportionately affected by AD. Recent research on AD has shown that there are clear disparities in the disease among racial groups, with higher prevalence and incidence in African Americans than the overall average. Pathologies for Alzheimer’s also seem to manifest differently in African Americans, including with neuroinflammation markers, cognitive decline, and biomarkers. Although there are genetic risk factors for Alzheimer’s, these account for few cases in all racial groups.

References

  1. 1 2 Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A (February 1988). "Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques". Annals of Neurology. 23 (2): 138–44. doi:10.1002/ana.410230206. PMID   2897823. S2CID   31389744.
  2. ↑ Katzman R (January 1993). "Education and the prevalence of dementia and Alzheimer's disease". Neurology. 43 (1): 13–20. doi:10.1212/wnl.43.1_part_1.13. PMID   8423876. S2CID   42469859.
  3. ↑ Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R (April 1994). "Influence of education and occupation on the incidence of Alzheimer's disease". JAMA. 271 (13): 1004–10. doi:10.1001/jama.1994.03510370056032. PMID   8139057.
  4. ↑ Satz P, Morgenstern H, Miller EN, Selnes OA, McArthur JC, Cohen BA, Wesch J, Becker JT, Jacobson L, D'Elia LF (May 1993). "Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the multicenter AIDS Cohort Study (MACS)". Journal of Acquired Immune Deficiency Syndromes. 6 (5): 503–11. doi:10.1097/00126334-199305000-00011. PMID   8483113.
  5. ↑ Wilson RS, Bennett DA, Gilley DW, Beckett LA, Barnes LL, Evans DA (December 2000). "Premorbid reading activity and patterns of cognitive decline in Alzheimer disease". Archives of Neurology. 57 (12): 1718–23. doi: 10.1001/archneur.57.12.1718 . PMID   11115237.
  6. ↑ Mori E, Hirono N, Yamashita H, Imamura T, Ikejiri Y, Ikeda M, Kitagaki H, Shimomura T, Yoneda Y (January 1997). "Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease". The American Journal of Psychiatry. 154 (1): 18–24. doi:10.1176/ajp.154.1.18. PMID   8988953.
  7. ↑ Mortimer JA, Snowdon DA, Markesbery WR (August 2003). "Head circumference, education and risk of dementia: findings from the Nun Study". Journal of Clinical and Experimental Neuropsychology. 25 (5): 671–9. doi:10.1076/jcen.25.5.671.14584. PMID   12815504. S2CID   20727671.
  8. ↑ Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL (June 2002). "Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis". Neuropathology and Applied Neurobiology. 28 (3): 218–27. doi:10.1046/j.1365-2990.2002.00385.x. PMID   12060346. S2CID   25125923.
  9. ↑ Mitoma H, Manto M, Hampe CS (2017). "Immune-mediated cerebellar ataxias: from bench to bedside". Cerebellum & Ataxias. 4: 16. doi: 10.1186/s40673-017-0073-7 . PMC   5609024 . PMID   28944066.
  10. ↑ Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, Mariën P, Nowak DA, Schmahmann JD, Serrao M, Steiner KM, Strupp M, Tilikete C, Timmann D, van Dun K (June 2016). "Consensus Paper: Revisiting the Symptoms and Signs of Cerebellar Syndrome". Cerebellum. 15 (3): 369–91. doi:10.1007/s12311-015-0687-3. PMC   5565264 . PMID   26105056.
  11. ↑ Mitoma, H.; Buffo, A.; Gelfo, F.; Guell, X.; Fucà, E.; Kakei, S.; Lee, J.; Manto, M.; Petrosini, L.; Shaikh, A. G.; Schmahmann, J. D. (February 2020). "Consensus Paper. Cerebellar Reserve: From Cerebellar Physiology to Cerebellar Disorders". Cerebellum (London, England). 19 (1): 131–153. doi:10.1007/s12311-019-01091-9. ISSN   1473-4230. PMC   6978437 . PMID   31879843.
  12. ↑ Ando J, Ono Y, Wright MJ (2001). "Genetic structure of spatial and verbal working memory". Behavioral Genetics. 31 (6): 615–24. doi:10.1023/A:1013353613591. PMID   11838538. S2CID   39136550.
  13. ↑ Swan GE, Carmelli D, Reed T, Harshfield GA, Fabsitz RR, Eslinger PJ (March 1990). "Heritability of cognitive performance in aging twins. The National Heart, Lung, and Blood Institute Twin Study". Archives of Neurology. 47 (3): 259–62. doi:10.1001/archneur.1990.00530030025010. PMID   2310310.
  14. ↑ Swan GE, Carmelli D (2002). Evidence for genetic mediation of executive control: a study of aging male twins. Journals of Gerontology Series B: Psychological Sciences and Social Sciences. 57(2):P133-43
  15. ↑ Plomin R, Pedersen NL, Lichtenstein P, McClearn GE (May 1994). "Variability and stability in cognitive abilities are largely genetic later in life". Behavior Genetics. 24 (3): 207–15. doi:10.1007/bf01067188. PMID   7945151. S2CID   6503298.
  16. ↑ Staff, Roger T.; Murray, Alison D.; Deary, Ian J.; Whalley, Lawrence J. (2004). "What provides cerebral reserve?". Brain. 127 (Pt 5): 1191–1199. doi: 10.1093/brain/awh144 . ISSN   0006-8950. PMID   15047587.
  17. 1 2 3 4 Nucci, Massimo; Mapelli, Daniela; Mondini, Sara (2012-06-01). "Cognitive Reserve Index questionnaire (CRIq): a new instrument for measuring cognitive reserve". Aging Clinical and Experimental Research. 24 (3): 218–26. doi:10.3275/7800. PMID   21691143. S2CID   7306499.
  18. 1 2 Mayeux, Richard; Prohovnik, Isak; Alexander, Gene E.; Stern, Yaakov (1992-09-01). "Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease". Annals of Neurology. 32 (3): 371–5. doi:10.1002/ana.410320311. PMID   1416806. S2CID   20777087.
  19. ↑ Groot C, van Loenhoud AC, Barkhof F, van Berckel BN, Koene T, Teunissen CC, Scheltens P, van der Flier WM, Ossenkoppele R (January 2018). "Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease". Neurology. 90 (2): e149–e156. doi:10.1212/WNL.0000000000004802. PMID   29237798. S2CID   10750586.
  20. ↑ Mungas D, Gavett B, Fletcher E, Farias ST, DeCarli C, Reed B (August 2018). "Education amplifies brain atrophy effect on cognitive decline: implications for cognitive reserve". Neurobiology of Aging. 68: 142–150. doi:10.1016/j.neurobiolaging.2018.04.002. PMC   5993638 . PMID   29798764.
  21. 1 2 3 Opdebeeck C, Martyr A, Clare L (2016-01-02). "Cognitive reserve and cognitive function in healthy older people: a meta-analysis" (PDF). Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 23 (1): 40–60. doi:10.1080/13825585.2015.1041450. PMID   25929288. S2CID   25058178.
  22. ↑ Stern Y, Gazes Y, Razlighi Q, Steffener J, Habeck C (September 2018). "A task-invariant cognitive reserve network". NeuroImage. 178: 36–45. doi:10.1016/j.neuroimage.2018.05.033. PMC   6409097 . PMID   29772378.
  23. 1 2 Lee DH, Lee P, Seo SW, Roh JH, Oh M, Oh JS, Oh SJ, Kim JS, Jeong Y (February 2019). "Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging". NeuroImage. 186: 690–702. doi:10.1016/j.neuroimage.2018.11.053. PMID   30503934. S2CID   53811225.
  24. ↑ Craik, Fergus I. M.; Bialystok, Ellen; Freedman, Morris (2010-11-09). "Delaying the onset of Alzheimer disease: bilingualism as a form of cognitive reserve". Neurology. 75 (19): 1726–1729. doi:10.1212/WNL.0b013e3181fc2a1c. PMC   3033609 . PMID   21060095.
  25. ↑ Ko, H; Kim, S; Kim, K; Jung, SH; Shim, I; Cha, S; Lee, H; Kim, B; Yoon, J; Ha, TH; Kwak, S; Kang, JM; Lee, JY; Kim, J; Park, WY; Nho, K; Kim, DK; Myung, W; Won, HH (24 May 2022). "Genome-wide association study of occupational attainment as a proxy for cognitive reserve". Brain: A Journal of Neurology. 145 (4): 1436–1448. doi:10.1093/brain/awab351. PMID   34613391.
  26. ↑ Scarmeas, Nikolaos; Zarahn, Eric; Anderson, Karen E.; Habeck, Christian G.; Hilton, John; Flynn, Joseph; Marder, Karen S.; Bell, Karen L.; Sackeim, Harold A.; Van Heertum, Ronald L.; Moeller, James R.; Stern, Yaakov (1 March 2003). "Association of Life Activities With Cerebral Blood Flow in Alzheimer Disease". Archives of Neurology. 60 (3): 359–65. doi:10.1001/archneur.60.3.359. PMC   3028534 . PMID   12633147.
  27. 1 2 3 Scarmeas, Nikolaos; Stern, Yaakov (2003). "Cognitive Reserve and Lifestyle". Journal of Clinical and Experimental Neuropsychology. 25 (5): 625–633. doi:10.1076/jcen.25.5.625.14576. ISSN   1380-3395. PMC   3024591 . PMID   12815500.
  28. 1 2 3 4 Clare, Linda; Wu, Yu-Tzu; Teale, Julia C.; MacLeod, Catherine; Matthews, Fiona; Brayne, Carol; Woods, Bob (2017-03-21). "Potentially modifiable lifestyle factors, cognitive reserve, and cognitive function in later life: A cross-sectional study". PLOS Medicine. 14 (3): e1002259. doi: 10.1371/journal.pmed.1002259 . ISSN   1549-1676. PMC   5360216 . PMID   28323829.
  29. ↑ Valenzuela, Michael J.; Matthews, Fiona E.; Brayne, Carol; Ince, Paul; Halliday, Glenda; Kril, Jillian J.; Dalton, Marshall A.; Richardson, Kathryn; Forster, Gill (2012). "Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia". Biological Psychiatry. 71 (9): 783–791. doi:10.1016/j.biopsych.2011.07.036. ISSN   0006-3223. PMID   22055015. S2CID   21944032.
  30. ↑ Hindle, John V.; Hurt, Catherine S.; Burn, David J.; Brown, Richard G.; Samuel, Mike; Wilson, Kenneth C.; Clare, Linda (2015-03-17). "The effects of cognitive reserve and lifestyle on cognition and dementia in Parkinson's disease-a longitudinal cohort study" (PDF). International Journal of Geriatric Psychiatry. 31 (1): 13–23. doi:10.1002/gps.4284. ISSN   0885-6230. PMID   25781584. S2CID   1589655.
  31. 1 2 Brown J, Cooper-Kuhn CM, Kempermann G, Van Praag H, Winkler J, Gage FH, Kuhn HG (May 2003). "Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis". The European Journal of Neuroscience. 17 (10): 2042–6. doi:10.1046/j.1460-9568.2003.02647.x. PMID   12786970. S2CID   25304270.
  32. 1 2 van Praag H, Christie BR, Sejnowski TJ, Gage FH (November 1999). "Running enhances neurogenesis, learning, and long-term potentiation in mice". Proceedings of the National Academy of Sciences of the United States of America. 96 (23): 13427–31. Bibcode:1999PNAS...9613427V. doi: 10.1073/pnas.96.23.13427 . PMC   23964 . PMID   10557337.
  33. 1 2 Maguire EA, Gadian DG, Johnsrude IS, Good CD, Ashburner J, Frackowiak RS, Frith CD (April 2000). "Navigation-related structural change in the hippocampi of taxi drivers". Proceedings of the National Academy of Sciences of the United States of America. 97 (8): 4398–403. Bibcode:2000PNAS...97.4398M. doi: 10.1073/pnas.070039597 . PMC   18253 . PMID   10716738.
  34. ↑ Crane PK, Gibbons LE, Arani K, Nguyen V, Rhoads K, McCurry SM, Launer L, Masaki K, White L (September 2009). "Midlife use of written Japanese and protection from late life dementia". Epidemiology. 20 (5): 766–74. doi:10.1097/EDE.0b013e3181b09332. PMC   3044600 . PMID   19593152.
  35. ↑ Craik FI, Bialystok E, Freedman M (November 2010). "Delaying the onset of Alzheimer disease: bilingualism as a form of cognitive reserve". Neurology. 75 (19): 1726–9. doi:10.1212/WNL.0b013e3181fc2a1c. PMC   3033609 . PMID   21060095.
  36. ↑ Stern, Yaakov (2012). "Cognitive reserve in ageing and Alzheimer's disease". The Lancet Neurology. 11 (11): 1006–1012. doi:10.1016/s1474-4422(12)70191-6. ISSN   1474-4422. PMC   3507991 . PMID   23079557.
  37. ↑ Nucci, Massimo; Mapelli, Daniela; Mondini, Sara (2011), Cognitive Reserve Index Questionnaire, American Psychological Association, doi:10.1037/t53917-000
  38. ↑ Stern, Yaakov (2009). "Cognitive reserve". Neuropsychologia. 47 (10): 2015–2028. doi:10.1016/j.neuropsychologia.2009.03.004. ISSN   0028-3932. PMC   2739591 . PMID   19467352.
  39. ↑ Mondini, Sara; Madella, Ileana; Zangrossi, Andrea; Bigolin, Angela; Tomasi, Claudia; Michieletto, Marta; Villani, Daniele; Di Giovanni, Giuseppina; Mapelli, Daniela (2016-04-26). "Cognitive Reserve in Dementia: Implications for Cognitive Training". Frontiers in Aging Neuroscience. 8: 84. doi: 10.3389/fnagi.2016.00084 . ISSN   1663-4365. PMC   4844602 . PMID   27199734.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.